# SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.

> **NCT03939741** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Bangladesh Laser & Cell Surgery Institute & Hospital** · enrollment: 31 (estimated)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **BIOLOGICAL:** SVF Containg Autologous Non Expanded ADSC

## Key facts

- **NCT ID:** NCT03939741
- **Lead sponsor:** Bangladesh Laser & Cell Surgery Institute & Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03939741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03939741, "SVF (Adipose Tissue Derived MSC) Based Therapy for CKD.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03939741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*